Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.42M Buy
18,274
+3,927
+27% +$481K 0.07% 260
2017
Q1
$1.77M Hold
14,347
0.05% 282
2016
Q4
$1.58M Buy
14,347
+6,114
+74% +$679K 0.05% 293
2016
Q3
$972K Hold
8,233
0.03% 410
2016
Q2
$921K Hold
8,233
0.03% 396
2016
Q1
$828K Hold
8,233
0.03% 428
2015
Q4
$875K Hold
8,233
0.03% 404
2015
Q3
$767K Hold
8,233
0.02% 430
2015
Q2
$857K Buy
8,233
+3,286
+66% +$342K 0.03% 406
2015
Q1
$536K Hold
4,947
0.02% 439
2014
Q4
$459K Hold
4,947
0.01% 477
2014
Q3
$432K Buy
4,947
+1,727
+54% +$156K ﹤0.01% 467
2014
Q2
$283K Hold
3,220
0.01% 558
2014
Q1
$272K Hold
3,220
0.01% 525
2013
Q4
$253K Hold
3,220
0.01% 518
2013
Q3
$274K Buy
+3,220
New +$271K 0.01% 476

Other funds holding LH

Delta Lloyd's LH Position: Q2 2017 in Review

Delta Lloyd increased its Labcorp (LH) stake by 27% in Q2 2017, buying an estimated $481K and bringing the position to 18,274 shares worth $2.42M. The position accounts for 0.07% of the portfolio, ranked #260.

Delta Lloyd first reported a position in LH in Q3 2013 and has held it in 16 quarters since. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Delta Lloyd held 18,274 shares of Labcorp worth $2.42M as of Q2 2017.
  • Delta Lloyd bought 3,927 Labcorp shares in Q2 2017, an estimated $481K.
  • Labcorp made up 0.07% of Delta Lloyd's portfolio in Q2 2017, its #260 holding.
  • Delta Lloyd first reported a position in Labcorp in Q3 2013 and has held it in 16 quarters since.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.